The shapewear brand, launched in 2019, is set to surpass $1B in sales in 2025. A new capital infusion will be used to expand ...
Near-term applications include combinations with kinase inhibitors (KIs)that achieve enhanced concentration at target sites and synergistic delivery of multiple KIs to the same location HOUSTON, TX / ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback